General description of Flibanserin (Addyi) Flibanserin, marketed under the brand name Addyi, is a medication approved by the United States Food and Drug Administration (FDA) to treat hypoactive sexual desire disorder (HSDD) in women. This condition is characterized by a persistent lack of sexual desire that causes distress or interpersonal difficulties. Originally developed as an antidepressant, Flibanserin works differently from other medications used to treat sexual dysfunction. It targets neurotransmitters in the brain, specifically serotonin and dopamine, which play a crucial role in regulating sexual desire. Flibanserin is available in tablet form, to be taken orally, and is typically prescribed …
Tag: Flibanserin, Flibanserin
Short general description of Flibanserin Flibanserin, also known by its brand name Addyi, is a medication approved by the FDA for the treatment of hypoactive sexual desire disorder (HSDD). It is primarily prescribed for premenopausal women who have experienced a persistent and distressing lack of sexual desire. Flibanserin works by targeting neurotransmitters in the brain, specifically serotonin and dopamine, which are involved in regulating sexual desire. It is classified as a serotonergic agonist and antagonist, as it both activates and blocks certain serotonin receptors. One of the main reasons why Flibanserin is considered a breakthrough medication is because HSDD is …